Clinical Trials
20 trialsThe Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone
State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital
WARP
Thomas Jefferson University
Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers
First Affiliated Hospital Xi'an Jiaotong University
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Henry Ford Health System
PAIR-PANCREAS
Assistance Publique - Hôpitaux de Paris
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma
Wake Forest University Health Sciences
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
DUOPAN-EPAM
Fundación para la Investigación del Hospital ClÃnico de Valencia
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
University of Arkansas
Whipple Procedure: A 5-year Clinical Experience in Tertiary Care Center
Services Hospital, Lahore
MIPA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CRIT
Providence Health & Services
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
M.D. Anderson Cancer Center
PLOT
GEM Hospital & Research Center
Net-Pac
CHIR-Net
Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy
Southwest Hospital, China
Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT
Benaroya Research Institute
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy
Università Vita-Salute San Raffaele